Hagenbuchner et al. 2010 demonstrated that Bortezomib-induced apoptosis in neuroblastoma cells activates the pro-apoptotic BH3-only proteins Noxa and Puma and induces repression of the anti-apoptotic Bcl2 family member Bcl-xL. Here, BCL2L1 is linked to neuroblastoma.